Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial

Sun, FF; Huang, WY; Chen, J; Zhao, LL; Zhang, DT; Wang, XD; Wan, WG; Dai, SM; Chen, S; Li, T; Ye, S

Ye, S (通讯作者)，Shanghai Jiao Tong Univ, Renji Hosp, Dept Rheumatol, Sch Med, Shanghai, Peoples R China.

LUPUS SCIENCE & MEDICINE, 2022; 9 (1):

Abstract

Introduction SLE is a chronic inflammatory systemic autoimmune disease with relapsing-remitting pattern. B-lymphocyte stimulator was involved in the p......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索